Spirochete-platelet attachment and thrombocytopenia in murine relapsing fever borreliosis

Blood

Volumn 102, Issue 8, 2003, Pages 2843-2850

  Alugupalli, Kishore R ^b   Michelson, Alan D ^b   Joris, Isabelle ^b   Schwan, Tom G ^b   Hodivala Dilke, Kairbaan ^b   Hynes, Richard O ^b   Leong, John M ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRIN; INTEGRIN ALPHA2B BETA3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; BACTERIUM ADHERENCE; BLEEDING TIME; BORRELIA HERMSII; BORRELIA INFECTION; CELL ADHESION; CONTROLLED STUDY; DISEASE SEVERITY; DISSEMINATED INTRAVASCULAR CLOTTING; HEMOSTASIS; IDIOPATHIC THROMBOCYTOPENIC PURPURA; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPIROCHETE; SPIROCHETE PLATELET ATTACHMENT; SPLENOMEGALY; THROMBOCYTE ACTIVATION; THROMBOCYTOPENIA;

EID: 0141889318     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-02-0426     Document Type: Article

References (61)

1. Wilson JJ, Neame PB, Kelton JG. Infection-induced thrombocytopenia. Semin Thromb Hemost. 1982;8:217-233.
2. Gainor JP, Morton CA, Bell DR, Vincent PA, Minnear FL. Platelet phospholipids decrease vascular endothelial permeability via a novel signaling pathway independent of cAMP/protein kinase A. Ann N Y Acad Sci. 2000;905:315-318.
3. Axthelm MK, Krakowka S. Canine distemper virus-induced thrombocytopenia. Am J Vet Res. 1987;48:1269-1275.
4. Murphy MF, Metcalfe P, Waters AH, et al. Incidence and mechanism of neutropenia and thrombocytopenia in patients with human immunodeficiency virus infection. Br J Haematol. 1987;66: 337-340.
5. Neame PB, Kelton JG, Walker IR, Stewart IO, Nossel HL, Hirsh J. Thrombocytopenia in septicemia: the role of disseminated intravascular coagulation. Blood. 1980;56:88-92.
6. Edwards CN, Nicholson GD, Hassell TA, Everard CO, Callender J. Thrombocytopenia in leptospirosis: the absence of evidence for disseminated intravascular coagulation. Am J Trop Med Hyg. 1986;35:352-354.
7. Greenwood BM, Whittle HC. Coagulation studies in Gambian trypanosomiasis. Am J Trop Med Hyg. 1976;25:390-394.
8. Des Prez RM, Steckley S, Stroud RM, Hawiger J. Interaction of Histoplasma capsulatum with human platelets. J Infect Dis. 1980;142:32-39.
9. Skudowitz RB, Katz J, Lurie A, Levin J, Metz J. Mechanisms of thrombocytopenia in malignant tertian malaria. Br Med J. 1973;2:515-518.
10. Davis CE. Thrombocytopenia: a uniform complication of African trypanosomiasis. Acta Trop. 1982;39:123-133.
11. Fajardo LF. Malarial parasites in mammalian platelets [letter]. Nature. 1973;243:298-299.
12. Alugupalli KR, Michelson AD, Barnard MR, et al. Platelet activation by a relapsing fever spirochete results in enhanced bacterium-platelet interaction via integrin αIIbβ3 activation. Mol Microbiol. 2001;39:330-340.
13. Southern PM, Sanford JP. Relapsing fever: a clinical and microbiological review. Medicine. 1969;48:129-149.
14. Barbour AG. Linear DNA of Borrelia species and antigenic variation. Trends Microbiol. 1993;1:236-239.
15. Stoenner HG, Dodd T, Larsen C. Antigenic variation of Borrelia hermsii. J Exp Med. 1982;156: 1297-1311.
16. Burgdorfer W. The epidemiology of the relapsing fever. In: Johnson RC, ed. The Biology of Parasitic Spirochetes. New York, NY: Academic Press; 1976:191-200.
17. Perine PL, Parry EHO, Vykovitch D, Warrell DA, Bryceson ADM. Bleeding in louse-borne relapsing fever, I: clinical studies with 37 patients. Trans R Soc Trop Med Hyg. 1971;65:776-781.
18. Salih SY, Mustafa D, Abdel Wahab SM, Ahmed MA, Omer A. Louse-borne relapsing fever, I: a clinical and laboratory study of 363 cases in the Sudan. Trans R Soc Trop Med Hyg. 1977; 71:43-48.
19. Butler T, Hazen P, Wallace CK, Awoke S, Habte-Michael A. Infection with Borrelia recurrentis: pathogenesis of fever and petechiae. J Infect Dis. 1979;140:665-675.
20. Dworkin MS, Anderson DE Jr, Schwan TG, et al. Tick-borne relapsing fever in the northwestern United States and southwestern Canada. Clin Infect Dis. 1998;26:122-131.
21. Fox JE. Platelet activation: new aspects. Haemostasis. 1996;26(suppl 4):102-131.
22. Phillips DR, Charo IF, Scarborough RM. GPIIb-IIIa: the responsive integrin. Cell. 1991;65:359-362.
23. Newman K Jr, Johnson RC. T-cell-independent elimination of Borrelia turicatae. Infect Immun. 1984;45:572-576.
24. Connolly SE, Benach JL. Cutting edge: the spirochetemia of murine relapsing fever is cleared by complement-independent bactericidal antibodies. J Immunol. 2001;167:3029-3032.
25. Alugupalli KR, Gerstein RM, Chen J, Szomolanyi-Tsuda E, Woodland RT, Leong JM. The resolution of relapsing fever borreliosis requires IgM and is concurrent with expansion of B1b lymphocytes. J Immunol. 2003;170:3819-3827.
26. Gebbia JA, Monco JC, Degen JL, Bugge TH, Benach JL. The plasminogen activation system enhances brain and heart invasion in murine relapsing fever borreliosis. J Clin Invest. 1999;103: 81-87.
27. Shamaei-Tousi A, Martin P, Bergh A, Burman N, Brannstrom T, Bergstrom S. Erythrocyte-aggregating relapsing fever spirochete Borrelia crocidurae induces formation of microemboli. J Infect Dis. 1999;180:1929-1938.
28. Alugupalli KR, Michelson AD, Barnard MR, Leong JM. Serial determinations of platelet counts in mice by flow cytometry. Thromb Haemost. 2001; 86:668-671.
29. Schwan TG, Hinnebusch BJ. Bloodstream-versus tick-associated variants of a relapsing fever bacterium. Science. 1998;280:1938-1940.
30. Thompson RS, Burgdorfer W, Russell R, Francis BJ. Outbreak of tick-borne relapsing fever in Spokane County, Washington. JAMA. 1969;210: 1045-1050.
31. Hinnebusch BJ, Barbour AG, Restrepo BI, Schwan TG. Population structure of the relapsing fever spirochete Borrelia hermsii as indicated by polymorphism of two multigene families that encode immunogenic outer surface lipoproteins. Infect Immun. 1998;66:432-440.
32. Hodivala-Dilke KM, McHugh KP, Tsakiris DA, et al. β 3-Integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. J Clin Invest. 1999;103:229-238.
33. Berger G, Hartwell DW, Wagner DD. P-Selectin and platelet clearance. Blood. 1998;92:4446-4452.
34. Manning KL, Novinger S, Sullivan PS, McDonald TP. Successful determination of platelet lifespan in C3H mice by in vivo biotinylation. Lab Anim Sci. 1996;46:545-548.
35. Dejana E, Callioni A, Quintana A, de Gaetano G. Bleeding time in laboratory animals, II: a comparison of different assay conditions in rats. Thromb Res. 1979;15:191-197.
36. Burstein SA, Adamson JW, Erb SK, Harker LA. Megakaryocytopoiesis in the mouse: response to varying platelet demand. J Cell Physiol. 1981; 109:333-341.
37. Schorer AE. Discordant effects on eicosanoids and fibrin degradation products in two murine models of antiphospholipid antibody. Thromb Res. 1997;85:295-304.
38. Tsakiris DA, Scudder L, Hodivala-Dilke K, Hynes RO, Coller BS. Hemostasis in the mouse (Mus musculus): a review. Thromb Haemost. 1999;81: 177-188.
39. Anda P, Sanchez-Yebra W, del Mar Vitutia M, et al. A new Borrelia species isolated from patients with relapsing fever in Spain. Lancet. 1996;348: 162-165.
40. George JN. Thrombocytopenia due to diminished or defective platelet production. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ, eds. Williams Hematology. New York, NY: McGraw-Hill; 1995: 1281-1289.
41. Carr JM, McKinney M, McDonagh J. Diagnosis of disseminated intravascular coagulation: role of D-dimer. Am J Clin Pathol. 1989;91:280-287.
42. Gillis S, Eldor A. Immune thrombocytopenic purpura in adults: clinical aspects. Baillieres Clin Haematol. 1998;11:361-372.
43. Wadenvik H, Stockelberg D, Hou M. Platelet proteins as autoantibody targets in idiopathic thrombocytopenic purpura. Acta Paediatr Suppl. 1998; 424:26-36.
44. Rand ML, Dean JA. Platelet function in autoimmune (idiopathic) thrombocytopenic purpura. Acta Paediatr Suppl. 1998;424:57-60.
45. Umekita LF, Carneiro SM, Mota I. One fate of epimastigote forms of Trypanosoma cruzi injected in mice: an ultrastructural study. J Parasitol. 1998; 84:1190-1195.
46. Aster RH. Pooling of platelets in the spleen: role in the pathogenesis of "hypersplenic" thrombocytopenia. J Clin Invest. 1966;45:645-657.
47. Pearson HA. The spleen and disturbances of splenic function. In: Nathan DG, Orkin SH, eds. Hematology of Infancy and Childhood. Vol 2. Philadelphia, PA: WB Saunders; 1987:1051-1068.
48. Woods VL, Wolff LE, Keller DM. Resting platelets contain a substantial centrally located pool of glycoprotein IIb-IIIa complex which may be accessible to some but not other extracellular proteins. J Biol Chem. 1986;261:15242-15251.
49. Ahmed MA, Abdel Wahab SM, Abdel Malik MO, et al. Louse-borne relapsing fever in the Sudan: a historical review and a clinico-pathological study. Trop Geogr Med. 1980;32:106-111.
50. Borgnolo G, Denku B, Chiabrera F, Hailu B. Louse-borne relapsing fever in Ethiopian children: a clinical study. Ann Trop Paediatr. 1993;13: 165-171.
51. Waxman L, Connolly TM. Isolation of an inhibitor selective for collagen-stimulated platelet aggregation from the soft tick Ornithodoros moubata. J Biol Chem. 1993;268:5445-5449.
52. Karczewski J, Endris R, Connolly TM. Disagregin is a fibrinogen receptor antagonist lacking the Arg-Gly-Asp sequence from the tick, Ornithodoros moubata. J Biol Chem. 1994;269:6702-6708.
53. Nienaber J, Gaspar AR, Neitz AW. Savignin, a potent thrombin inhibitor isolated from the salivary glands of the tick Ornithodoros savignyi (Acari: Argasidae). Exp Parasitol. 1999;93:82-91.
54. Borjesson DL, Simon SI, Tablin F, Barthold SW. Thrombocytopenia in a mouse model of human granulocytic ehrlichiosis. J Infect Dis. 2001;184: 1475-1479.
55. Magoun L, Zuckert WR, Robbins D, et al. Variable small protein- (Vsp-) dependent and Vsp-independent pathways for glycosaminoglycan recognition by relapsing fever spirochetes. Mol Microbiol. 2000;36:886-897.
56. Yeaman MR, Sullam PM, Dazin PF, Bayer AS. Platelet microbicidal protein alone and in combination with antibiotics reduces Staphylococcus aureus adherence to platelets in vitro. Infect Immun. 1994;62:3416-3423.
57. Sullam PM, Frank U, Yeaman MR, Tauber MG, Bayer AS, Chambers HF. Effect of thrombocytopenia on the early course of streptococcal endocarditis. J Infect Dis. 1993;168:910-914.
58. Polack B, Delolme F, Peyron F. Protective role of platelets in chronic (Balb/C) and acute (CBA/J) Plasmodium berghei murine malaria. Haemostasis. 1998;27:278-285.
59. Peyron F, Polack B, Lamotte D, Kolodie L, Ambroise-Thomas P. Plasmodium falciparum growth inhibition by human platelets in vitro. Parasitology. 1989;99(pt 3):317-322.
60. Umekita LF, Mota I. Role of platelets in the in vivo removal of Trypanosoma cruzi from circulation. Braz J Med Biol Res. 1990;23:593-596.
61. Umekita LF, Piazza RM, Mota I. Role of platelets and complement in the clearance of epimastigote forms of Trypanosoma cruzi. Braz J Med Biol Res. 1994;27:2391-2399.